Skip to main content

Table 2 Maternal Outcomes

From: A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion

 

Serial IV Bolus

Continuous Infusion

(n = 100)

(n = 100)

Discharged prior to delivery - N (%)

0

6 (6%)

Missing Data

1

3

 

(n = 99)

(n = 91)

Labor induced - N (%)

17 (17.2%)

10 (11%)

Mode of delivery

Vaginal- N (%)

22 (22.2%)

15 (16.5%)

Forceps - N (%)

1 (1.0%)

3 (3.2)

Cesarean - N (%)

76 (76.8%)

73 (80.2%)

Postpartum Hemorrhage - N (%)

1 (1.0%)

0

Blood products after trial entry - N (%)

0

0

Seizures - N (%)

0

0

Maternal Deaths - N (%)

0

0